期刊文献+

中国2004~2009年甲型病毒性肝炎流行病学特征分析 被引量:109

Epidemiological Analysis of Hepatitis A in China During 2004-2009
原文传递
导出
摘要 目的了解中国(未包括香港、澳门特别行政区和台湾地区,下同)2004~2009年甲型病毒性肝炎(甲肝)的流行病学特征,为预防控制甲肝提供流行病学依据。方法利用中国法定传染病报告系统数据,进行甲肝描述性流行病学分析。结果中国2004~2009年甲肝报告发病率分别为7.20/10万、5.61/10万、5.37/10万、5.98/10万、4.34/10万、3.30/10万;报告病例主要集中在河南、四川、云南、贵州、新疆、甘肃省(自治区,下同),6个省甲肝病例数占当年全国总病例数44%~51%。近30%的病例为<15岁儿童,病例主要为农民和学生。2004~2009年报告甲肝突发公共卫生事件主要集在中、小学校,病例主要为在校学生。结论中国2004~2009年甲肝报告发病数(率)逐年下降,表明以甲肝疫苗预防接种为主的预防控制措施成效显著;加强甲肝监测,及时发现、调查、处理甲肝聚集性病例,可有效控制甲肝疫情爆发。 Objective To understand the epidemic situation of hepatitis A in China during 2004-2009 and provide the scientific basis for controlling hepatitis A in the future.Methods The data of hepatitis A from NNDRS during 2004-2009 was analyzed by Excel 97.Results During 2004-2009,the reported incidence of hepatitis A was 7.20/100 000,5.61/100 000,5.37/100 000,5.98/100 000,4.34/100 000 and 3.30/100 000 respectively.The Hepatitis A cases were mainly reported in some provinces including Henan,Sichuan,Yunnan,Guizhou,Gansu,and Xinjiang Provinces.About 50% of the reported hepatitis A cases during 2004-2009 were from those provinces.About 30% of hepatitis A cases were children under 15 years old.The reported emergency public affairs mostly happened in the elementary and high schools.And the reported cases were primarily students on campus.Conclusion The results revealed that the reported incidence of Hepatitis A has gradually decreased and the effectiveness of hepatitis A prevention and control has achieved enormous success,especially hepatitis A vaccination。
出处 《中国疫苗和免疫》 CAS 2010年第5期453-456,共4页 Chinese Journal of Vaccines and Immunization
关键词 甲型病毒性肝炎 流行病学特征 Hepatitis A Epidemiology
  • 相关文献

参考文献3

二级参考文献18

  • 1唐耀武.我国应该注意加强甲型肝炎的预防[J].医学研究杂志,2006,35(2):6-7. 被引量:4
  • 2郑徽,卢永,王富珍,崔富强.中国2004~2006年甲型病毒性肝炎疫情分析[J].中国计划免疫,2007,13(4):336-340. 被引量:65
  • 3杨敏姬 朱小中 葛成富 等.小学生接种甲型肝炎活疫苗后血清抗体及反应性观察[J].中华预防医学杂志,1990,24(5):306-306.
  • 4Feinstone SM,Kapikian AZ,Purcell RH.Hepatitis A:Detection by immune electron microscope of a viruslike antigen associated with acute illness[J].Science,1973,182(116):1026-1028.
  • 5Innis B,Snitbhsn R,Kunssol P,et al.Protection agaist hepatitis A by an inactivated Vaccine[J].JAMA,1994,271 (17):1328.
  • 6Piazza M,Sa(?)ary A,,Vegnente A,Soncini R,Pensati P,Sardo M,Orlando R,Tosone G,Picciotto L.Safety and immunogenicity of hepatitis A vaccine in infants:a candidate for inclusion in the childhood vaccination programme. Vaccine . 1999
  • 7Thomson JA,Kennedy R,Thompson SC.Hepatitis A vaccination of child care workers in Victoria:are recommendations being implemented?. Australian and New Zealand Journal of Public Health . 1998
  • 8Xu ZY,Li RC,Meng ZD,Zhang Y,Yan CK,Zhou TK,Wang XY,Gong J,Li YP,Wang SP,Huang QC,Zhao YL,Ma JC,Shi TS,Liu XL,Xia JL,Li YT,Liu HB,Ouyang PY.Immunogenicity and efficacy trials of live attenuated hepatitis A vaccines. Chinese Medical Journal . 1998
  • 9Das,A.An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology . 1999
  • 10J. S. Mao S. A. Chai R. Y. Xie N. L. Chen Q. Jiang X. Z. Zhu S. Y. Zhang H. Y. Huang H. W. Mao X. N. Bao and C. J. Liu.Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine . 1997

共引文献138

同被引文献697

引证文献109

二级引证文献456

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部